5 September 2022
Forxiga approved in China for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes…
Imfinzi plus chemotherapy approved in the US as the first immunotherapy regimen for patients with advanced biliary tract cancer…
To be effected by means of a scheme of arrangement under Part 26 of the Companies Act 2006 …
1 September 2022
Laxman will be replaced by Nicandro Durante, current Senior Independent Director, who will step into the role of CEO, as the Board evaluates and selects the future leadership….
CAMELLIA PLC INTERIM RESULTS Camellia Plc (AIM:CAM) announces its interim results for the six months ended 30 June 2022. Malcolm Perkins,…
31 August 2022
Half-year Report – six months ended 30 June 2022…
Sale of non-core petrol forecourt business enables Co-op to focus on core convenience proposition whilst significantly deleveraging and strengthening the Group's balance sheet…
Disposal of interests in Agricultural Supplies Division with a streamlined focus on being an international leader in manufacturing value added products and solutions in Speciality Agriculture and Engineering…